Revenue ($USD) : $1,070,602,040
Revenue (foreign currencies) : NZ$1,742,800,000
R&D spend : $121,754,260
Employees : 7,141
Fiscal year end : 3/31/2024
CEO : Lewis Gradon

www.fphcare.com/us

Fisher & Paykel Healthcare designs and manufactures systems for acute and chronic respiratory care, surgery, and obstructive sleep apnea treatment. The company distributes its products in more than 120 countries. After two years of revenue decline, Fisher & Paykel boosted sales by 10% during its most recent fiscal year, moving up six spots on the Medtech Big 100. –CN